중환자실 섬망의 약물요법
Pharmacotherapy for Delirium in the Intensive Care Units
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Delirium is defined as an acute disturbance of consciousness with inattention difficulties, changes in cognition or perceptual disturbance, which can develop over hours to days. Delirium is common in the medical and surgical intensive care units (ICU) and associated with many negative outcomes such as increased mortality, ICU and hospital length of stay, and cognitive impairment. A large number of studies have been conducted on various nonpharmacologic and pharmacologic strategies for prevention or treatment of delirium. The purpose of this article was to review the nonpharmacologic and pharmacologic agents used for delirium and review current studies on each strategy. Nonpharmacologic delirium managements using early mobilization and spontaneous awakening trials/spontaneous breathing trials have been demonstrated to reduce the incidence or duration of delirium in ICU patients. Pharmacologic medications such as haloperidol, atypical antipsychotics (e.g., risperidone, olanzapine, quetiapine, ziprasidone), and dexmedetomidine can be used to treat delirium in the ICU, although there are limited data on when to treat and which agents to use. Haloperidol and atypical antipsychotics have the potential to cause QT prolongation and should be used cautiously in ICU patients.
Abstract
Delirium is defined as an acute disturbance of consciousness with inattention difficulties, changes in cognition or perceptual disturbance, which can develop over hours to days. Delirium is common in the medical and surgical intensive care units (ICU) and associated with many negative outcomes such as increased mortality, ICU and hospital length of stay, and cognitive impairment. A large number of studies have been conducted on various nonpharmacologic and pharmacologic strategies for prevention or treatment of delirium. The purpose of this article was to review the nonpharmacologic and pharmacologic agents used for delirium and review current studies on each strategy. Nonpharmacologic delirium managements using early mobilization and spontaneous awakening trials/spontaneous breathing trials have been demonstrated to reduce the incidence or duration of delirium in ICU patients. Pharmacologic medications such as haloperidol, atypical antipsychotics (e.g., risperidone, olanzapine, quetiapine, ziprasidone), and dexmedetomidine can be used to treat delirium in the ICU, although there are limited data on when to treat and which agents to use. Haloperidol and atypical antipsychotics have the potential to cause QT prolongation and should be used cautiously in ICU patients.
참고문헌 (52)
- Reade M. C., "Sedation and delirium in the intensive care unit", N Engl J Med, 370(5), pp.444~454 (2014)
- "Diagnostic and statistical manual of mental disorders", American Psychiatric Association, ~ (2011)
- American Psychiatric Association, "American Psychiatric Association Practice Guidelines for the Treatment of Psychiatric Disorders", American Psychiatric Association, 72~74 (2006)
- Davidson J.E., "Pain, agitation, and delirium guidelines: nurses’involvement in development and implementation", Crit Care Nurse, 35(3), pp.17~31 (2015)
- Peterson J. F., "Delirium and its motoric subtypes:a study of 614 critically ill patients", J Am Geriatr Soc, 54(3), pp.479~484 (2006)
- Bergeron N., "Intensive Care Delirium Screening Checklist: evaluation of a new screening tool", Intensive Care Med, 27(5), pp.859~864 (2001)
- Ely E. W., "Apolipoprotein E4 polymorphism as a genetic predisposition to delirium in critically ill patients", Crit Care Med, 35(1), pp.112~117 (2007)
- Milbrandt E. B., "Costs associated with delirium in mechanically ventilated patients", Crit Care Med, 32(4), pp.955~962 (2004)
- Shehabi Y., "SEDCOM(Safety and Efficacy of Dexmedetomidine Compared With Midazolam) Study Group.: Delirium duration and mortality in lightly sedated, mechanically ventilated intensive care patients", Crit Care Med, 38(12), pp.2311~2318 (2010)
- Pisani M. A., "Days of delirium are associated with 1-year mortality in an older intensive care unit population", Am J Respir Crit Care Med, 180(11), pp.1092~1097 (2009)
- Ely E. W., "Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit", JAMA, 291(14), pp.1753~1762 (2004)
- Ely E. W., "The impact of delirium in the intensive care unit on hospital length of stay", Intensive Care Med, 27(12), pp.1892~1900 (2007)
- Girard T. D., "Delirium as a predictor of long-term cognitive impairment in survivors of critical illness", Crit Care Med, 38(7), pp.1513~1520 (2010)
- "Icudelirium website"[URL]
- Gunther M. L., "VISIONS Investigation, VISualizing Icu SurvivOrs Neuroradiological Sequelae.: The association between brain volumes, delirium duration, and cognitive outcomes in intensive care unit survivors: the VISIONS cohort magnetic resonance imaging study", Crit Care Med, 40(7), pp.2022~2032 (2012)
- Morandi A., "VISIONS Investigation, VISualizing Icu SurvivOrs Neuroradiological Sequelae.: The relationship between delirium duration, white matter integrity, and cognitive impairment in intensive care unit survivors as determined by diffusion tensor imaging: the VISIONS prospective cohort magnetic resonance imaging study", Crit Care Med, 40(7), pp.2182~2189 (2012)
- Ely E. W., "Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU)", JAMA, 286(21), pp.2703~2710 (2001)
- Bergeron N., "Intensive Care Delirium Screening Checklist: evaluation of a new screening tool", Intensive Care Med, 27(5), pp.859~864 (2001)
- Pandharipande P., "Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients", Anesthesiology, 104(1), pp.21~26 (2006)
- Van Rompaey B., "Risk factors for delirium in intensive care patients: a prospective cohort study", Crit Care, 13(3), pp.77~ (2009)
- Balas M. C., "Effectiveness and safety of the awakening and breathing coordination, delirium monitoring", management, and early exercise, Crit Care Med, pp.2014, 42(5)[DOI]
- Schweickert W. D., "Early physical and occupational therapy in mechanically ventilated, critically ill patients: a randomised controlled trial", Lancet, 373(9678), pp.1874~1882 (2009)
- Needham D. M., "Early physical medicine and rehabilitation for patients with acute respiratory failure: a quality improvement project", Arch Phys Med Rehabil, 91(4), pp.536~542 (2010)
- Girard T. D., "Efficacy and safety of a paired sedation and ventilator weaning protocol for mechanically ventilated patients in intensive care (Awakening and Breathing Controlled trial): a randomised controlled trial", Lancet, 371(9607), pp.126~134 (2008)
- Khan B.A., "Effectiveness of implementing a wake up and breathe program on sedation and delirium in the ICU", Crit Care Med, 42(12), pp.e791~e795 (2014)
- Wang W., "Haloperidol prophylaxis decreases delirium incidence in elderly patients after noncardiac surgery: a randomized controlled trial", Crit Care Med, 40(3), pp.731~739 (2012)
- van den Boogaard M., "Haloperidol prophylaxis in critically ill patients with a high risk for delirium", Crit Care, 17(1), pp.R9~ (2013)
- Shehabi Y., "Prevalence of delirium with dexmedetomidine compared with morphine based therapy after cardiac surgery: a randomized controlled trial (DEXmedetomidine COmpared to Morphine-DEXCOM Study)", Anesthesiology, 111(5), pp.1075~1084 (2009)
- Pasin L., "Dexmedetomidine reduces the risk of delirium, agitation and confusion in critically ill patients: a meta-analysis of randomized controlled trials", J Cardiothorac Vasc Anesth, 28(6), pp.1459~1466 (2014)
- Prakanrattana U., "Efficacy of risperidone for prevention of postoperative delirium in cardiac surgery", Anaesth Intensive Care, 35(5), pp.714~719 (2007)
- Serafim R. B., "Pharmacologic prevention and treatment of delirium in intensive care patients: A systematic review", J Crit Care, 30(4), pp.799~807 (2015)
- Hudetz J. A., "Ketamine attenuates delirium after cardiac surgery with cardiopulmonary bypass", J Cardiotho-rac Vasc Anesth, 23(5), pp.651~657 (2009)
- Page V. J., "Statin use and risk of delirium in the critically ill", Am J Respir Crit Care Med, 189(6), pp.666~673 (2014)
- Casarin A., "Evaluating early administration of the hydroxymethylglutaryl-CoA reductase inhibitor simvastatin in the prevention and treatment of delirium in critically ill ventilated patients (MoDUS trial): study protocol for a randomized controlled trial", Trials, 16(16), pp.218~ (2015)
- Jacobi J., "Task Force of the American College of Critical Care Medicine(ACCM) of the Society of Critical Care Medicine(SCCM)., American Society of Health-System Pharmacists (ASHP)., American College of Chest Physicians.: Clinical practice guidelines for the sustained use of sedatives and analgesics in the critically ill adult", Crit Care Med, 30(1), pp.119~141 (2002)
- Girard T. D., "Feasibility, efficacy, and safety of antipsychotics for intensive care unit delirium: the MIND randomized, placebo-controlled trial", Crit Care Med, 38(2), pp.428~437 (2010)
- Page V. J., "Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): a randomised, double-blind, placebo-controlled trial", Lancet Respir Med, 1(7), pp.515~523 (2013)
- Mo Y., "Rational Use of Second-Generation Antipsychotics for the Treatment of ICU Delirium: A Neurophar-macological Approach", J Pharm Pract, 1 (2015)
- Skrobik Y. K., "Olanzapine vs haloperidol:treating delirium in a critical care setting", Intensive Care Med, 30(3), pp.444~449 (2003)
- Kim K. S., "An open pilot trial of olanzapine for delirium in the Korean population", Psychiatry Clin Neurosci, 55(5), pp.515~519 (2001)
- Devlin J. W., "Efficacy and safety of quetiapine in critically ill patients with delirium: A prospective, multicenter, randomized, double-blind, placebo-controlled pilot study", Crit Care Med, 38(2), pp.419~427 (2010)
- Tahir T. A., "A randomized controlled trial of quetiapine versus placebo in the treatment of delirium", J Psychosom Res, 69(5), pp.485~490 (2010)
- Hakim S. M., "Early treatment with risperidone for subsyndromal delirium after on-pump cardiac surgery in the elderly: a randomized trial", Anesthesiology, 116(5), pp.987~997 (2012)
- Shehabi Y., "Prevalence of delirium with dexmedetomidine compared with morphine based therapy after cardiac surgery: a randomized controlled trial (DEXmedetomidine COmpared to Morphine-DEXCOM Study)", Anesthesiology, 111(5), pp.1075~1084 (2009)
- Reade M.C., "Dexmedetomidine vs. haloperidol in delirious, agitated, intubated patients: a randomised open-label trial", Crit Care, 13(3), pp.R75~ (2009)
- Riker R. R., "Dex-medetomidine vs midazolam for sedation of critically ill patients: a randomized trial", JAMA, 301(5), pp.489~499 (2009)
- Pandharipande P.P., "MENDS investigators.: Effect of dexmedetomidine versus lorazepam on outcome in patients with sepsis: an a priori-designed analysis of the MENDS randomized controlled trial", Crit Care, 14(2), pp.R38~ (2010)
- Michaud C. J., "Early pharmacological treatment of delirium may reduce physical restraint use: a retrospective study", Ann Pharmacother, 48(3), pp.328~334 (2014)
- Sharma N. D., "Torsades de Pointes associated with intravenous haloperidol in critically ill patients", Am J Cardiol, 81(2), pp.238~240 (1998)
- Raschi E., "Torsadogenic risk of antipsychotics:combining adverse event reports with drug utilization data across Europe", PLoS One, 8(11), pp.e81208~ (2013)
- Tisdale J. E., "The effect of intravenous haloperidol on QT interval dispersion in critically ill patients: comparison with QT interval prolongation for assessment of risk of Torsades de Pointes", J Clin Pharmacol, 41(12), pp.1310~1318 (2001)
- Tisdale J. E., "Accuracy of uncorrected versus corrected QT interval for prediction of torsade de pointes associated with intravenous haloperidol", Pharmacotherapy, 27(2), pp.175~182 (2007)
